Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionCwm, Llc
Latest Disclosed Ownership79,113 shares
Latest Disclosed Value $ 12,084,498
Cwm, Llc reports 4.77% decrease in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 14, 2026 - Cwm, Llc filed a 13F-HR form disclosing ownership of 79,113 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $12,084,511 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 83,074 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -4.77% during the quarter. The current value of the position is $11,365,374 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 79,113 -3,961 -4.77 12,084 109,754.55 0.0314
2026-01-26 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 83,074 -6,402 -7.15 11 0.00 0.0310
2025-10-15 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 89,476 6,817 8.25 11 10.00 0.0345
2025-07-25 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 82,659 13,687 19.84 10 42.86 0.0353
2025-05-01 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 68,972 -2,337 -3.28 8 16.67 0.0307
2025-02-04 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 71,309 -4,096 -5.43 7 -25.00 0.0288
2024-10-08 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 75,405 -5,412 -6.70 9 0.00 0.0373
2024-07-10 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 80,817 -1,795 -2.17 9 14.29 0.0406
2024-04-05 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 82,612 -3,832 -4.43 8 -12.50 0.0389
2024-02-01 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 86,444 -1,204 -1.37 9 0.00 0.0469
2023-10-11 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 87,648 -4,589 -4.98 9 -11.11 0.0547
2023-08-03 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 92,237 -3,071 -3.22 9 12.50 0.0575
2023-05-01 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 95,308 -2,177 -2.23 9 0.00 0.0592
2023-02-01 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 97,485 -3,976 -3.92 9 -99.90 0.0651
2022-10-27 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 101,461 5,341 5.56 7,712 -5.08 0.0613
2022-07-28 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 96,120 3,971 4.31 8,125 0.48 0.0629
2022-04-21 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 92,149 3,262 3.67 8,086 4.00 0.0574
2022-01-31 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 88,887 335 0.38 7,775 -3.77 0.0547
2021-09-15 2021-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 88,552 0 0.00 8,080 0.00 0.0644
2021-07-29 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 88,552 0 8,080 0.0644
2021-09-15 2021-03-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 88,552 0 0.00 8,080 0.00 0.0644
2021-04-27 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 85,723 -2,829 7,328 0.0645
2021-09-15 2020-12-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 88,552 0 0.00 8,080 0.00 0.0644
2021-01-27 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 86,946 -1,606 8,210 0.0769
2021-09-15 2020-09-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 88,552 0 0.00 8,080 0.00 0.0644
2020-10-19 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 92,632 4,080 8,055 0.0896
2021-09-15 2020-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 88,552 0 0.00 8,080 0.00 0.0644
2020-07-22 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 113,257 24,705 9,892 0.1173
2021-09-15 2020-03-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 88,552 0 0.00 8,080 0.00 0.0644
2020-04-28 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 115,038 26,486 9,485 0.1412
2021-09-14 2019-12-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 88,552 0 0.00 8,080 0.00 0.0644
2020-01-27 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 104,424 15,872 9,888 0.1263
2021-09-14 2019-09-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 88,552 0 0.00 8,080 0.00 0.0644
2019-10-22 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 79,567 -8,985 6,914 0.1006
2021-09-14 2019-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 88,552 0 0.00 8,080 0.00 0.0644
2019-07-31 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 59,408 -29,144 5,425 0.0897
2021-09-02 2019-03-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 88,552 72,448 449.88 8,080 484.66 0.0644
2019-04-22 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 35,810 19,706 3,443 0.0691
2019-01-25 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 16,104 12,659 367.46 1,382 365.32 0.0345
2018-10-29 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,445 2,935 575.49 297 661.54 0.0076
2018-07-31 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 510 70 15.91 39 8.33 0.0013
2018-04-26 2018-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 440 96 27.91 36 24.14 0.0014
2018-01-16 2017-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 344 -145 -29.65 29 -30.95 0.0013
2017-10-16 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 489 221 82.46 42 90.91 0.0020
2017-07-17 2017-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 268 51 23.50 22 37.50 0.0011
2017-04-17 2017-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 217 -782 -78.28 16 -78.08 0.0009
2017-01-19 2016-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 999 132 15.22 73 7.35 0.0045
2016-10-17 2016-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 867 100 13.04 68 7.94 0.0047
2016-07-21 2016-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 767 17 2.27 63 16.67 0.0046
2016-04-18 2016-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 750 -44 -5.54 54 -20.59 0.0047
2016-02-01 2015-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 794 44 5.87 68 -1.45 0.0066
2015-10-30 2015-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 750 50 7.14 69 23.21 0.0069
2014-02-14 2013-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 700 -435 -38.33 56 -35.63 0.0087
2013-11-14 2013-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,135 1,135 87 0.0228
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.